Literature DB >> 12731578

A monoclonal mouse anti-rat Ia antibody which cross reacts with a human HLA-DRw determinant.

W R McMaster1, B C Winearls, P Parham.   

Abstract

A mouse monoclonal antibody, called MRC OX 3, which detects a polymorphic Ia determinant in the rat and cross reacts with an Ia determinant coded for by the I-A subregion in the mouse, detects a polymorphic determinant on human B cell lines. MRC OX 3 antibody binds to human B cell lines which express HLA-DRw specificities DRw 1, DRw2 and DRw6 but does not bind to those cells which only express other HLA-DRw specificities. No significant binding of MRC OX 3 antibody to either normal or mitogen stimulated human peripheral blood leukocytes, some of which are typed as HLA-DRw1, DRw2 or DRw6, could be detected. The binding of MRC OX 3 antibody to a human B cell line could be completely inhibited by pre-absorbing the antibody with purified rat Ia antigen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 12731578     DOI: 10.1111/j.1399-0039.1979.tb00875.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.

Authors:  V Quaranta; M A Pellegrino; G N Callahan; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Evolution of HLA antigenic determinants: species cross-reactions of monoclonal antibodies.

Authors:  F M Brodsky; P Parham
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Cell surface properties of HLA antigens on Epstein-Barr virus-transformed cell lines.

Authors:  L M Smith; H R Petty; P Parham; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  A monoclonal antibody recognizing HLA-DR2 on malignant and activated cells.

Authors:  S V Fuggle; J Kirkley; A Ting; P J Morris
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.